• Lupin to acquire Symbiomix Therapeutics expressbpd
    October 12, 2017
    Lupin announced that its US subsidiary, Lupin has acquired Symbiomix Therapeutics. Lupin had entered into an option to acquire the company earlier this year.
  • Lupin scoops up women's health specialist Symbiomix for $150 million pharmafile
    October 12, 2017
    The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics for $150 million in a move to double down on its offerings in the women’s health market.
PharmaSources Customer Service